학술논문
Ex Vivo Drug Sensitivity Testing to Predict Response to Venetoclax + Azacitidine in Acute Myeloid Leukemia: Interim Results of the Prospective Multicenter Phase II Venex Trial
Document Type
Article
Author
Kuusanmäki, Heikki; Kytölä, Sari; Vänttinen, Ida; Ranta, Amanda; Ruokoranta, Tanja; Holopainen, Annasofia; Koskela, Sirpa; Kuusisto, Milla E.L.; Porkka, Kimmo; Räty, Riikka; Västrik, Imre; Wennerberg, Krister; Heckman, Caroline A.; Ettala, Pia; Pyörälä, Marja; Rimpiläinen, Johanna; Siitonen, Timo; Kontro, Mika
Source
Blood; November 2021, Vol. 138 Issue: Supplement 1 p228-228, 1p
Subject
Language
ISSN
00064971; 15280020
Abstract
Kuusanmäki: AbbVie: Research Funding. Heckman: Novartis: Research Funding; Orion Pharma: Research Funding; Celgene/BMS: Research Funding; Oncopeptides: Consultancy, Research Funding; Kronos Bio, Inc.: Research Funding. Ettala: Novartis: Membership on an entity's Board of Directors or advisory committees; Pfizer: Membership on an entity's Board of Directors or advisory committees; Amgen: Other: Conference expensens; Sanofi: Other: Conference expensens. Pyörälä: Pfizer: Honoraria; Novartis: Honoraria; AbbVie: Honoraria. Rimpiläinen: Astellas: Membership on an entity's Board of Directors or advisory committees; AbbVie: Membership on an entity's Board of Directors or advisory committees; Pfizer: Membership on an entity's Board of Directors or advisory committees. Siitonen: amgen: Honoraria; Novartis: Honoraria, Membership on an entity's Board of Directors or advisory committees; Brystol Myers Squibb: Consultancy; Janssen-Cilag: Consultancy, Membership on an entity's Board of Directors or advisory committees; abbvie: Membership on an entity's Board of Directors or advisory committees; Pfizer: Consultancy, Membership on an entity's Board of Directors or advisory committees; celgene: Membership on an entity's Board of Directors or advisory committees. Kontro: Astellas: Consultancy, Membership on an entity's Board of Directors or advisory committees; Jazz Pharmaceuticals: Membership on an entity's Board of Directors or advisory committees; AbbVie: Membership on an entity's Board of Directors or advisory committees, Research Funding.